| [1]Lage H.An overview of cancer multidrug resistance: a still unsolved problem[J].Cell Mol Life Sci, 2008, 65(20):3145-3167[2]Wu Q, Yang Z, Nie Y, et al.Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches[J].Cancer Lett, 2014, 347(2):159-166[3]Ziebarth AJ, Nowsheen S, Steg AD, et al.Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer[J].Clin Cancer Res, 2013, 19(1):170-182[4]Casorelli I, Bossa C, Bignami M.DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias[J].Int J Environ Res Public Health, 2012, 9(8):2636-2657[5]Doerks T, Copley RR, Schultz J, et al.Systematic identification of novel protein domain families associated with nuclear functions[J].Genome Res, 2002, 12(1):47-56[6]Reese MJ, Savina PM, Generaux GT, et al.In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor[J].Drug Metab Dispos, 2013, 41(2):353-361[7]Rochat B.Importance of influx and efflux systems and xenobiotic metabolizing enzymes in intratumoral disposition of anticancer agents[J].Curr Cancer Drug Targets, 2009, 9(5):652-674[8]Davidson AL, Dassa E, Orelle C, et al.Structure, function, and evolution of bacterial ATP-binding cassette systems[J].Microbiol Mol Biol Rev, 2008, 72(2):317-364[9]Walker JE, Saraste M, Runswick MJ, et al.Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold[J].EMBO J, 1982, 1(8):945-995[10]Prachayasittikul V, Worachartcheewan A, Shoombuatong W, et al.Classification of P-glycoprotein-interacting compounds using machine learning methods[J].EXCLI J, 2015, 14:958-970[11]Vasiliou V, Vasiliou K, Nebert DW.Human ATP-binding cassette (ABC) transporter family[J].Hum Genomics, 2009, 3(3):281-290[12]Rice AJ, Park A, Pinkett HW.Diversity in ABC transporters: type I, II and III importers[J].Crit Rev Biochem Mol Biol, 2014, 49(5):426-437[13]Levatic J, Curak J, Kralj M, et al.Accurate models for P-gp drug recognition induced from a cancer cell line cytotoxicity screen[J].J Med Chem, 2013, 56(14):5691-5708[14]Borst P, Schinkel AH.P-glycoprotein ABCB1: a major player in drug handling by mammals[J].J Clin Invest, 2013, 123:4131-4133[15]Cui C, Xue YN, Wu M, et al.Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles[J].Biomaterials, 2013, 34(15):3858-3869[16]Sharom FJ.Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function[J].Front Oncol, 2014, 4:41-[17]Bao L, Haque A, Jackson K, et al.Increased of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model[J].Am J Pathol, 2011, 178(2):838-852[18]Kruh GD, Belinsky MG.The MRP family of drug efflux pumps[J].Oncogene, 2003, 22(47):7537-7552[19]Cole SP.Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future[J].Annu Rev Pharmacol Toxicol, 2014, 54:95-117[20]Bakos E, Evers R, Szakács G, et al.Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain[J].J Biol Chem, 1998, 273(48):32167-32175[21]尹继业，张建亭.MRP1/ABCC1基因多态性:从发现到临床应用[J].中南大学学报（医学版）, 2011, 36(10):927-938[22]Mo W, Zhang JT.Human ABCG2: structure, function, and its role in multidrug resistance[J].Int J Biochem Mol Biol, 2012, 3(1):1-27[23]Mao Q, Unadkat JD.Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update[J].AAPS J, 2015, 17(1):65-82[24]Noguchi K, Katayama K, Sugimoto Y.Human ABC transporter ABCG2/BCRP in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics[J].Pharmgenomics Pers Med, 2014, 7:53-64[25]Chen Z, Shi T, Zhang L, et al.Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade[J].Cancer Lett, 2016, 370(1):153-164[26]Theodoulou FL, Kerr ID.ABC transporter research: going strong 40 years on[J].Biochem Soc Trans, 2015, 43(5):1033-1040[27]Fire A, Xu S, Montgomery MK, et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature, 1998, 391(6669):806-811[28]Zhu CY, Lv YP, Yan DF, et al.Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells[J].Asian Pac J Cancer Prev, 2013, 14(11):6757-6760[29]Materna V, Stege A, Surowiak P, et al.RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells[J].Biochem Biophys Res Commun, 2006, 348(1):153-157[30]Wang XM, Gao SJ, Guo XF, et al.CIAPIN1 gene silencing enhances chemosensitivity in a drug-resistant animal model in vivo[J].Braz J Med Biol Res, 2014, 47(4):273-278[31]Corrêa S, Binato R, Du Rocher B,et al.Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia[J].BMC cancer, 2012, 12:303-[32]Fan TY, Wang H, Xiang P,et al.Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma[J].Int J Clin Exp Pathol, 2014, 7(10):6662-6670[33]To KK.MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy[J].J Biomed Sci, 2013, 20:99-[34]Feng DD, Zhang H, Zhang P, et al.Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia[J].J Cell Mol Med, 2011, 15:2164-2175[35]Bao L, Hazari S, Mehra S, et al.Increased of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298[J].Am J Pathol, 2012, 180:2490-2503[36]Kovalchuk O, Filkowski J, Meservy J, et al.Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin[J].Mol Cancer Ther, 2008, 7(7):2152-2159[37]Binkhathlan Z, Lavasanifar A.P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives[J].Curr Cancer Drug Targets, 2013, 13(3):326-346[38]Silva R, Vilas-Boas V, Carmo H, et al.Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy[J].Pharmacol Ther, 2015, 149:1-123[39]Mealey KL, Fidel J.P-glycoprotein mediated drug interactions in animals and humans with cancer[J].J Vet Intern Med, 2015, 29(1):1-6[40]Wang Z, Ravula R, Cao M, et al.Transporter-mediated multidrug resistance and its modulation by Chinese medicines and other herbal products[J].Curr Drug Discov Technol, 2010, 7(1):54-66[41]Abdallah HM, Al-Abd AM, El-Dine RS, et al.P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review[J].J Adv Res, 2015, 6(1):45-62[42]Wang B, Pu Y, Xu B, et al.Self-microemulsifying Drug Delivery System Improved Oral Bioavailability of 20(S)-Protopanaxadiol: From Preparation to Evaluation[J].Chem Pharm Bull, 2015, 63(9):688-693[43]Tan W, Lu J, Huang M, et al.Anti-cancer natural products isolated from chinese medicinal herbs[J].Chin Med, 2011, 6(1):27-[44]Jia L, Zhao Y, Liang XJ..Current evaluation of the millennium phytomedicine- ginseng (II): Collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine[J].Curr Med Chem, 2009, 16(22):2924-2942[45]Han X, Quinney SK, Wang Z, et al.Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach[J].Clin Pharmacol Ther, 2015, 98(3):321-327[46]Liang S, Deng F, Xing H, et al.P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug-herb/drug-drug interactions[J].Drug Des Devel Ther, 2014, 8:475-483[47]Farabegoli F, Papi A, Bartolini G, et al.(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line[J].Phytomedicine, 2010, 17(5):356-362[48]Xu D, Lu Q, Hu X.Down-regulation of P-glycoprotein in MDR breast cancer cell MCF-7/ADR by honokiol[J].Cancer Lett, 2006, 243(2):274-280[49]Kim SS, Seong S, Kim SY.Synergistic effect of ginsenoside Rg3 with verapamil on the modulation of multidrug resistance in human acute myeloid leukemia cells[J].Oncol Lett, 2014, 7(4):1265-1269[50]Wang X, Deng R, Lu Y,et al.Gambogic acid as a non-competitive inhibitor of ATP-binding cassette transporter B1 reverses the multidrug resistance of human epithelial cancers by promoting ATP-binding cassette transporter B1 protein degradation[J].Basic Clin Pharmacol Toxicol, 2013, 112(1):25-33[51]Weber DA, Wheat JM, Currie GM.Cancer stem cells and the impact of Chinese herbs, isolates and other complementary medical botanicals: a review[J].中西医结合学报, 2012, 10(5):493-503 |
